European journal of gynaecological oncology · 2011
Prognosis and role of postmastectomy radiotherapy in patients with T1-T2 breast cancer with one to three positive axillary nodes.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Z, Hao J, Zhuang H, Yu J
Аннотация
PURPOSE: To evaluate the prognosis and role of postmastectomy radiotherapy (PMRT) in T1-T2 breast cancer with one to three positive axillary nodes.
METHODS: The 10-year Kaplan-Meier locoregional recurrence (LRR), distant recurrence (DR), disease-free survival (DFS) and overall survival (OS) were compared between the NO and 1-3N+ cohorts. The role of PMRT was evaluated in the 1-3N+ cohort.
RESULTS: The 10-year LRR, DR, DFS, OS rates in NO and the 1-3N+ cohorts were as follows: LRR 7.5% vs 19.4% (p = 0.011); DR 14.4% vs 23.0% (p = 0.029); DFS 71.3% vs 51.2% (p = 0.001) and OS 77.0% vs 58.7% (p = 0.001). Of the 192 1-3N+ patients not treated and treated with PMRT, the outcomes were: LRR 20.1% vs 18.4% (p = 0.047); DR 26.4% vs 21.5% (p = 0.743); DFS 40.2% vs 55.4% (p = 0.260) and OS 40.7% vs 66.0% (p = 0.344), respectively.
CONCLUSION: PMRT reduces the 10-year LRR rate for such patients, but further examination is needed.
METHODS: The 10-year Kaplan-Meier locoregional recurrence (LRR), distant recurrence (DR), disease-free survival (DFS) and overall survival (OS) were compared between the NO and 1-3N+ cohorts. The role of PMRT was evaluated in the 1-3N+ cohort.
RESULTS: The 10-year LRR, DR, DFS, OS rates in NO and the 1-3N+ cohorts were as follows: LRR 7.5% vs 19.4% (p = 0.011); DR 14.4% vs 23.0% (p = 0.029); DFS 71.3% vs 51.2% (p = 0.001) and OS 77.0% vs 58.7% (p = 0.001). Of the 192 1-3N+ patients not treated and treated with PMRT, the outcomes were: LRR 20.1% vs 18.4% (p = 0.047); DR 26.4% vs 21.5% (p = 0.743); DFS 40.2% vs 55.4% (p = 0.260) and OS 40.7% vs 66.0% (p = 0.344), respectively.
CONCLUSION: PMRT reduces the 10-year LRR rate for such patients, but further examination is needed.